New oral contraceptive, Estrostep

January 1997

Parke-Davis will introduce a new oral contraceptive, Estrostep. It'll be out soon in the U.S...possibly later in Canada.

It's "triphasic"...20 mcg of ethinyl estradiol for 5 days...30 mcg for 7 days...then 35 mcg for the last 9 days. Always a fixed dose of progestin.

Overall, it's comparable to a 30 mcg estrogen pill.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

More discussions about increasing prescription drug information for patients
Antifungals Some patients take ketoconazole (Nizoral) tablets with a cola beverage
Antifungals Amphotericin B ORAL suspension
Antifungals New LIPID formulations of IV amphotericin B
Diabetes Computer software programs for diabetics
Diabetes Rezulin (troglitazone) for Type II diabetes
Contraceptives Closer look at vaginal spermicides
Contraceptives New oral contraceptive, Estrostep
Contraceptives Drug interactions with contraceptives
Alzheimer's Disease Drugs that might help reduce the risk of Alzheimer's
Alzheimer's Disease New drug to TREAT Alzheimer's called Aricept (donepezil)
Eating Disorders The new appetite suppressant, Redux (dexfenfluramine) for binge eating
Cardiology New COMBINATION drugs for hypertension
Cardiology Several alternatives for patients who get a chronic cough from ACE inhibitors
Cardiology Beta blockers to reduce the risk of heart attack or heart failure after surgery
Thrombolytics New thrombolytic, Retavase (reteplase)
Asthma Leukotriene antagonists for asthma
Women's Health Common symptom of menopause is oral discomfort
Practice Chart of significant new drugs approved by the FDA and HPB in 1996